{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T20:33:41Z","timestamp":1786739621045,"version":"build-2736575974"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T00:00:00Z","timestamp":1619136000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.4103\/1673-5374.313044","type":"journal-article","created":{"date-parts":[[2021,4,25]],"date-time":"2021-04-25T11:35:03Z","timestamp":1619350503000},"page":"2420-2421","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["A pilot exploration with Posiphen to normalize amyloid precursor protein in Down syndrome"],"prefix":"10.4103","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9799-7246","authenticated-orcid":false,"given":"Xu-Qiao","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Neurosciences, University of California San Diego, La Jolla, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,12]]},"reference":[{"key":"R1-20260525","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-019-0143-7","article-title":"Down syndrome","volume":"6","author":"Antonarakis","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"R2-20260525","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3389\/fnins.2019.00659","article-title":"Alzheimer disease pathogenesis: insights from molecular and cellular biology studies of oligomeric Abeta and Tau species","volume":"13","author":"Chen","year":"2019","journal-title":"Front Neurosci"},{"key":"R3-20260525","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3389\/fnins.2019.00446","article-title":"Exploring the pathogenesis of alzheimer disease in basal forebrain cholinergic neurons: converging insights from alternative hypotheses","volume":"13","author":"Chen","year":"2019","journal-title":"Front Neurosci"},{"key":"R4-20260525","article-title":"Targeting increased levels of APP in Down syndrome: Posiphen-mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model","author":"Chen","year":"2020","journal-title":"Alzheimers Dement"},{"key":"R5-20260525","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3233\/JAD-160836","article-title":"Down syndrome, partial Trisomy 21, and absence of Alzheimer's Disease: the role of APP","volume":"56","author":"Doran","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"R6-20260525","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.1523\/JNEUROSCI.0578-19.2019","article-title":"Lysosomal dysfunction in Down syndrome is APP-dependent and mediated by APP-betaCTF (C99)","volume":"39","author":"Jiang","year":"2019","journal-title":"J Neurosci"},{"key":"R7-20260525","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1126\/science.aba4624","article-title":"Antisense oligonucleotides for neurodegeneration","volume":"367","author":"Leavitt","year":"2020","journal-title":"Science"},{"key":"R8-20260525","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/jnnp-2012-302589","article-title":"Posiphen as a candidate drug to lower CSF amyloid precursor protein, amyloid-beta peptide and tau levels: target engagement, tolerability and pharmacokinetics in humans","volume":"83","author":"Maccecchini","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R9-20260525","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1096\/fj.201700359","article-title":"Amyloid precursor protein and endosomal-lysosomal dysfunction in Alzheimer's disease: inseparable partners in a multifactorial disease","volume":"31","author":"Nixon","year":"2017","journal-title":"FASEB J"},{"key":"R10-20260525","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.stemcr.2018.05.004","article-title":"The impact of APP on Alzheimer-like pathogenesis and gene expression in Down syndrome iPSC-derived neurons","volume":"11","author":"Ovchinnikov","year":"2018","journal-title":"Stem Cell Reports"},{"key":"R11-20260525","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/ana.410430316","article-title":"Molecular mapping of Alzheimer-type dementia in Down's syndrome","volume":"43","author":"Prasher","year":"1998","journal-title":"Ann Neurol"},{"key":"R12-20260525","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuron.2006.05.022","article-title":"Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration","volume":"51","author":"Salehi","year":"2006","journal-title":"Neuron"},{"key":"R13-20260525","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.trci.2017.12.001","article-title":"Translational inhibition of APP by Posiphen: Efficacy, pharmacodynamics, and pharmacokinetics in the APP\/PS1 mouse","volume":"4","author":"Teich","year":"2018","journal-title":"Alzheimers Dement (N Y)"},{"key":"R14-20260525","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1172\/JCI82409","article-title":"Amyloid precursor protein-mediated endocytic pathway disruption induces axonal dysfunction and neurodegeneration","volume":"126","author":"Xu","year":"2016","journal-title":"J Clin Invest"}],"container-title":["Neural Regeneration Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/1673-5374.313044","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:30:35Z","timestamp":1786735835000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1673-5374.313044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,23]]},"references-count":14,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/1673-5374.313044","relation":{},"ISSN":["1673-5374","1876-7958"],"issn-type":[{"value":"1673-5374","type":"print"},{"value":"1876-7958","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,23]]},"assertion":[{"value":"2020-11-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}